{"id":9811,"date":"2013-10-10T09:56:58","date_gmt":"2013-10-10T13:56:58","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=9811"},"modified":"2013-10-10T10:00:54","modified_gmt":"2013-10-10T14:00:54","slug":"amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811","title":{"rendered":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/10\/2013 (wallstreetpr) &#8211;\u00a0Amarin Corporation plc (ADR) (NASDAQ:AMRN) has set Oct. 16 as the date for conference call to deliberate the results from the meeting of FDA advisory committee regarding its patented Vascepa drug. This conference call comes ahead of the Q3.13 earnings release on Nov. 4.<\/p>\n<p style=\"text-align: justify;\">The biopharmaceutical company is seeking approval of Vascepa in treatment of high triglycerides in adults. The drug is proposed as an adjunct to diet. The AMRN senior management will deliver keynote speeches on the conference day which is set to begin 7.00 pm ET.<\/p>\n<p style=\"text-align: justify;\">AMRN is a well-known name in the biopharm industry as the company has deep interest and contribution in cardiovascular health. It particularly develops and commercializes therapeutics for cardiovascular conditions.<\/p>\n<p style=\"text-align: justify;\">Customarily, FDA advisory committee steps in to offer independent advice to the Food and Drugs Administration on matters relating to veterinary and human drugs under which AMRN\u2019s Vascepa falls. This advisory body also dispenses advice to FDA on vaccines, med products and services as well as food. The advisory committee brings together industry players, consumers and other stakeholders in the food and drugs sector.<\/p>\n<p style=\"text-align: justify;\">The details about the FDA\u2019s advisory committee results have not yet been made public until the conference call on Wednesday. However, observers are already dispensing their views of what to expect on the market and stock exchange platform if AMRN gets away with its proposal for the new drug.<\/p>\n<p style=\"text-align: justify;\">For a drug developer the size and statue of AMRN, investor community is more interested on just how great this new drug can translate into fat revenue.<\/p>\n<p style=\"text-align: justify;\">For this reason, several analysts are tempted to paint a bullish image of the stock in the exchange market.\u00a0 AMRN currently has a market value of $1.08 billion. It\u2019s 52-week long rally trade at $12.96 on the upper boundary and $5.12 on the lower boundary. The stock shed 5.83 ($0.39) to close down at $6.30 on Wednesday.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/10\/2013 (wallstreetpr) &#8211;\u00a0Amarin Corporation plc (ADR) (NASDAQ:AMRN) has set Oct. 16 as the date for conference call to deliberate the results from the [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":9812,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3314,3312,432,3313],"stock_ticker":[],"class_list":["post-9811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-amarin-corporation-plc-adr","tag-amarin-corporation-plc-adr-nasdaqamrn","tag-amrn","tag-nasdaqamrn","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/10\/2013 (wallstreetpr) &#8211;\u00a0Amarin Corporation plc (ADR) (NASDAQ:AMRN) has set Oct. 16 as the date for conference call to deliberate the results from the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-10T13:56:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-10-10T14:00:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16\",\"datePublished\":\"2013-10-10T13:56:58+00:00\",\"dateModified\":\"2013-10-10T14:00:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\"},\"wordCount\":327,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg\",\"keywords\":[\"Amarin Corporation plc (ADR)\",\"Amarin Corporation plc (ADR) (NASDAQ:AMRN)\",\"AMRN\",\"NASDAQ:AMRN\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\",\"name\":\"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg\",\"datePublished\":\"2013-10-10T13:56:58+00:00\",\"dateModified\":\"2013-10-10T14:00:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811","og_locale":"en_US","og_type":"article","og_title":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR","og_description":"Boston, MA 10\/10\/2013 (wallstreetpr) &#8211;\u00a0Amarin Corporation plc (ADR) (NASDAQ:AMRN) has set Oct. 16 as the date for conference call to deliberate the results from the [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-10-10T13:56:58+00:00","article_modified_time":"2013-10-10T14:00:54+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16","datePublished":"2013-10-10T13:56:58+00:00","dateModified":"2013-10-10T14:00:54+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811"},"wordCount":327,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg","keywords":["Amarin Corporation plc (ADR)","Amarin Corporation plc (ADR) (NASDAQ:AMRN)","AMRN","NASDAQ:AMRN"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811","url":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811","name":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg","datePublished":"2013-10-10T13:56:58+00:00","dateModified":"2013-10-10T14:00:54+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/621.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amarin-corporation-plc-adr-nasdaqamrn-conference-call-on-patented-vascepa-coming-up-october-16-9811#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Amarin Corporation plc (ADR) (NASDAQ:AMRN) Conference Call On Patented Vascepa Coming Up October 16"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=9811"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/9811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/9812"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=9811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=9811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=9811"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=9811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}